Get the Stockscreener App
5.35
4.29%
-0.24
Pre-market:
5.36
0.01
+0.19%
Sophia Genetics Sa stock is traded at $5.35, with a volume of 385.26K.
It is down -4.29% in the last 24 hours and up +8.30% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$5.59
Open:
$5.55
24h Volume:
385.26K
Relative Volume:
2.35
Market Cap:
$448.84M
Revenue:
$81.18M
Net Income/Loss:
$-80.94M
P/E Ratio:
-4.5304
EPS:
-1.1809
Net Cash Flow:
$-55.15M
1W Performance:
-5.98%
1M Performance:
+8.30%
6M Performance:
+14.56%
1Y Performance:
+75.99%
1-Day Range:
$5.25
$5.89
1-Week Range:
$5.25
$6.30
52-Week Range:
$2.81
$6.30
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
5.35 | 484.08M | 81.18M | -80.94M | -55.15M | -1.1809 |
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Craig Hallum | Buy |
| Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
SOPHiA GENETICS (SOPH) chair sells 83,679 shares and exercises options - Stock Titan
SOPH (NASDAQ) affiliate sells via 10b5-1; 50,069-share trade listed - Stock Titan
Form 144 SOPHIA GENETICS SA For: 29 June - Investing.com UK
Form 144 SOPHIA GENETICS SA For: 29 June By Investing.com - Investing.com South Africa
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $290,400.20 in Stock - MarketBeat
JURGI CAMBLONG (SOPH) lists 10b5-1 sales, largest 50,069 shares on 06/26/2026 - Stock Titan
SOPHiA GENETICS (NASDAQ: SOPH) CEO sells 51,442 shares under Rule 10b5-1 plan - Stock Titan
Enterprise value to EBIT forward of SOPHiA GENETICS SA – NASDAQ:SOPH - TradingView
Enterprise value to EBITDA forward of SOPHiA GENETICS SA – NASDAQ:SOPH - TradingView
Enterprise value to EBITDA forward of SOPHiA GENETICS SA – DUS:90B - TradingView
Price to earnings forward of SOPHiA GENETICS SA – NASDAQ:SOPH - TradingView
Price to earnings forward of SOPHiA GENETICS SA – DUS:90B - TradingView
Price to book forward of SOPHiA GENETICS SA – NASDAQ:SOPH - TradingView
Enterprise value to EBIT forward of SOPHiA GENETICS SA – DUS:90B - TradingView
Enterprise value to revenue forward of SOPHiA GENETICS SA – DUS:90B - TradingView
Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA - GuruFocus
SOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 5,000 Shares of Stock - MarketBeat
Jurgi Camblong sells shares under 10b5-1 plan — SOPH (NASDAQ: SOPH) - Stock Titan
SOPHiA GENETICS (SOPH) CMO sells 5,000 shares in Rule 10b5-1 trade - Stock Titan
SOPHiA GENETICS (SOPH) CTO sells shares to cover tax withholding - Stock Titan
SOPH|Sophia Genetics SA|Price:5.750| - TradingKey
Form 144 SOPHIA GENETICS SA For: 25 June - Investing.com UK
SOPHiA GENETICS SA Actuals & Estimates (NASDAQ:SOPH) - TradingView
Form 144 SOPHIA GENETICS SA For: 25 June By Investing.com - Investing.com Nigeria
SOPH (NASDAQ: SOPH) insider sells tens of thousands of shares under 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) CFO’s small 774-share sale covers RSU tax bill - Stock Titan
SOPHiA GENETICS (SOPH) president sells 422 shares to cover RSU taxes - Stock Titan
Is SOPHiA GENETICS SA (SOPH) Among the Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On? - Insider Monkey
Total debt per share of SOPHiA GENETICS SA – DUS:90B - TradingView
Cash flow from operating activities of SOPHiA GENETICS SA – DUS:90B - TradingView
SOPHiA GENETICS SA Cash Flow – DUS:90B - TradingView
Basic earnings per share (basic EPS) of SOPHiA GENETICS SA – DUS:90B - TradingView
Form 144 SOPHIA GENETICS SA For: 22 June By Investing.com - Investing.com South Africa
SOPHiA GENETICS Completes USD57.5 Million Nasdaq Share Offering - Global Legal Chronicle
Form 144 SOPHIA GENETICS SA For: 22 June - Investing.com UK
SOPH (NASDAQ: SOPH) affiliate notifies sale of 774 RSU shares, recent 10b5-1 trades listed - Stock Titan
Ross J Muken 10b5-1 sales reported (SOPH) via Morgan Stanley - Stock Titan
Director Troy Cox receives new SOPHiA GENETICS (SOPH) RSU and option grants - Stock Titan
SOPHiA GENETICS (SOPH) director receives RSU and option grants as equity pay - Stock Titan
SOPHiA GENETICS (SOPH) director gets RSU and option grants - Stock Titan
SOPHiA GENETICS (SOPH) director granted RSUs and 28,818 share options - Stock Titan
SOPHiA GENETICS (SOPH) director granted RSUs and options vesting at next meeting - Stock Titan
SOPHiA GENETICS Publishes Results of the 2026 Annual General Meeting - The AI Journal
Form 6K Sophia Genetics SA For: 22 June By Investing.com - Investing.com South Africa
SOPHiA GENETICS Publishes Results of the 2026 Annual General Mee - GuruFocus
[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC FilingForm 6-K - Stock Titan
SOPHiA GENETICS Shareholders Back 2025 Results, Board Line-Up and Capital Changes at June 18 AGM - TipRanks
SOPHiA GENETICS raises USD 57.5 million through a public offering - Startupticker.ch
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offeri - GuruFocus
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares - Barchart.com
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sophia Genetics Sa Stock (SOPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Camblong Jurgi | Executive Chairman |
Jun 29 '26 |
Option Exercise |
3.16 |
18,060 |
57,070 |
3,619,553 |
| Camblong Jurgi | Executive Chairman |
Jun 30 '26 |
Sale |
6.11 |
65,269 |
398,632 |
3,581,293 |
| Camblong Jurgi | Executive Chairman |
Jun 29 '26 |
Sale |
5.87 |
18,410 |
108,058 |
3,601,143 |
1.79%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):